References
- GardulfAImmunoglobulin treatment for primary antibody deficiencies: advantages of the subcutaneous routeBiodrugs200721210511617402794
- BussePJRazviSCunningham-RundlesCEfficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiencyJ Allergy Clin Immunol200210961001100412063531
- GardulfANicolayUReplacement IgG therapy and self-therapy at home improve the health-related quality of life in patients with primary antibody deficienciesCurr Opin Allergy Clin Immunol20066643444217088648
- GardulfABjorvellHAndersenVLifelong treatment with gammaglobulin for primary antibody deficiencies: the patients’ experiences of subcutaneous self-infusions and home therapyJ Adv Nurs19952159179277541407
- NicolayUKiesslingPBergerMHealth-related quality of life and treatment satisfaction in North American patients with primary immunedeficiency diseases receiving subcutaneous IgG self-infusions at homeJ Clin Immunol2006261657216418804
- GardulfANicolayUMathDChildren and adults with primary antibody deficiencies gain quality of life by subcutaneous IgG self-infusions at homeJ Allergy Clin Immunol2004114493694215480339
- AbolhassaniHSadaghianiMSAghamohammadiAOchsHDRezaeiNHome-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysisJ Clin Immunol20123261180119222730009
- ShapiroRSWhy I use subcutaneous immunoglobulin (SCIG)J Clin Immunol201333Suppl 2S95S9823264027
- KobrynskiLSubcutaneous immunoglobulin therapy: a new option for patients with primary immunodeficiency diseasesBiologics2012627728722956859
- ShapiroRSubcutaneous immunoglobulin therapy by rapid push is preferred to infusion by pump: a retrospective analysisJ Clin Immunol201030230130720082124
- NicolayUHaagSEichmannFHergetSSpruckDGardulfAMeasuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapyQual Life Res20051471683169116119180
- WareJSnowKKosinskiMSF-36 Health Survey Manual and Interpretation GuideLincoln, RIQualityMetric Inc2000
- BharmalMPayneKAtkinsonMJDesrosiersMPMoriskyDEGemmenEValidation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medicationsHealth Qual Life Outcomes200973619397800
- BuchiSBuddebergCKlaghoferRPreliminary validation of PRISM (Pictorial Representation of Illness and Self Measure)–a brief method to assess sufferingPsychother Psychosom200271633334112411768
- BuchiSSenskyTPRISM: pictorial representation of illness and self measure. A brief nonverbal measure of illness impact and therapeutic aid in psychosomatic medicinePsychosomatics199940431432010402877
- RushtonAHeneghanNRHeapAWhiteLCalvertMGoodwinPCPatient and physiotherapist perceptions of rehabilitation following primary lumbar discectomy: a qualitative focus group study embedded within an external pilot and feasibility trialBMJ Open201774e015878
- CrespoCSantosSCanavarroMCKielpikowskiMPryorJFéres-CarneiroTFamily routines and rituals in the context of chronic conditions: a reviewInt J Psychol201348572974623848452
- SmithRCLeinCCollinsCTreating patients with medically unexplained symptoms in primary careJ Gen Intern Med200318647848912823656
- GardulfAClinical experiences in primary and secondary immunodeficiencies and immune-mediated conditions using Gammanorm®Immunotherapy20168563364727020964
- SextonSLoflinR3rdThe relief of getting a diagnosisAm Fam Physician20098011122319961133
- Haute Autorité de Santé. Patient et professionnels de santé: décider ensemble. Concept, aides destinées aux patients et impact de la décision médicale partagée Etat des lieux [French National Authority for Health. Concept, patient support and the impact of shared medical decision. Current status]. French National Authority for Health Location: Saint-Denis, France; 2013.